Authors: Mirochnick, M Cooper, E Capparelli, E McIntosh, K Lindsey, J Xu, J Jacobus, D Mofenson, L Bonagura, VR Nachman, S Yogev, R Sullivan, JL Spector, SA

Citation: M. Mirochnick et al., Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection, CLIN PHARM, 70(1), 2001, pp. 24-32

Authors: McIntosh, K Cooper, E Xu, J Mirochnick, M Lindsey, J Jacobus, D Mofenson, L Yogev, R Spector, SA Sullivan, JL Sacks, H Kovacs, A Nachman, S Sleasman, J Bonagura, V McNamara, J

Citation: K. Mcintosh et al., Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus, PEDIAT INF, 18(5), 1999, pp. 432-439

Authors: Mirochnick, M Cooper, E McIntosh, K Xu, J Lindsey, J Jacobus, D Mofenson, L Sullivan, JL Dankner, W Frenkel, LM Nachman, S Wara, DW Johnson, D Bonagura, VR Rathore, MH Cunningham, CK McNamara, J

Citation: M. Mirochnick et al., Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children, ANTIM AG CH, 43(11), 1999, pp. 2586-2591